| Literature DB >> 35010502 |
Abstract
This study sought to confirm the effect of using a mouthwash containing Glycyrrhiza uralensis extract for oral health management by investigating changes in the pH of dental plaque and bacteria that cause dental caries. A randomized, double-blind, placebo-controlled study was conducted on 60 subjects categorized in either the Glycyrrhiza uralensis extract gargle group (n = 30) or the saline gargle group (n = 30). Scaling was conducted in order to ensure the homogeneity of the oral environment, while gargling was performed once daily before the subjects went to bed for 5 days based on the group. Caries activity was assessed using the Cariview test, while detection of the bacteria that cause dental caries was confirmed using microbiological analysis. All clinical measurements and evaluations were conducted by two trained dental hygienists under the supervision of a dentist. Based on the analysis of dental caries activity and dental caries-causing bacteria, the Glycyrrhiza uralensis extract gargle group showed a clear decrease in bacteria compared to the saline gargle group. Glycyrrhiza uralensis extract demonstrated no risk of tooth demineralization. It also showed excellent antibacterial activity through inhibition and effective reduction of bacteria that cause dental caries. Therefore, the mouthwash containing Glycyrrhiza uralensis extract is an effective oral care product suitable for use as an effective dental caries prevention agent.Entities:
Keywords: Glycyrrhiza uralensis extract; dental caries; mouthwash; preventive effect; randomized controlled trial
Mesh:
Substances:
Year: 2021 PMID: 35010502 PMCID: PMC8751079 DOI: 10.3390/ijerph19010242
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Research flow diagram.
Figure 2The criteria according to the pH value by the Cariview test.
Primers and probes used in the real-time PCR assays.
| Bacteria | Target Genes | Primers/Probe Sets | Amplicon Size (bp) |
|---|---|---|---|
|
| mannitol-specific enzyme II (mtlA) gene | 5′-CAGCGCATTCAACACAAGCA-3′ 103 | 103 |
|
| 16S ribosomal RNA gene | 5′-GTACAACGAGTCGCAAGCCG-3′ 149 | 149 |
|
| sialidase (nanH) gene | 5′-GCTCCCTCATGCTCAACTCG-3′ | 140 |
Characteristics of the subjects in the two groups.
| Characteristics | N (%) | |||
|---|---|---|---|---|
| Saline |
| |||
| * Gender | Male | 7 (23.3) | 9 (30.0) | 0.771 |
| Female | 23 (76.7) | 21 (70.0) | ||
| ¥ Age (mean ± SD) | 44.27 ± 11.5 | 45.53 ± 11.22 | 0.821 | |
| * Systemic disease | No disease | 24 (80.0) | 26 (86.7) | 0.731 |
| Have a disease | 6 (20.0) | 4 (13.3) | ||
| * Marriage | Single | 14 (46.7) | 13 (43.3) | 1.000 |
| Married | 16 (53.3) | 17 (56.7) | ||
¥p-values are determined by the independent t-test (p < 0.05), * p-values are determined by the chi-square test (p < 0.05).
Changes in the Cariview scores of the two groups.
| Variables | Group | Mean ± SD | * | ||
|---|---|---|---|---|---|
| Baseline | Treatment | After 5 Days | |||
| Cariview | Saline | 54.94 ± 6.95 a | 54779 ± 4.01 a | 60.22 ± 2.73 a | 0.056 |
|
| 54.89 ± 7.55 a | 44.04 ± 4.13 b | 45.54 ± 4.91 b |
| |
| ¥ | 0.990 |
|
| ||
| Risk | Saline | 2.07 ± 0.13 a | 2.00 ± 0.00 a | 2.17 ± 0.19 a | 0.057 |
|
| 2.10 ± 0.15 a | 1.90 ± 0.15 b | 1.90 ± 0.15 b |
| |
| ¥ | 0.705 | 0.083 |
| ||
¥p-values are determined by independent t-test (p < 0.05), * p-values are determined by one-way ANOVA and Tukey tests (p < 0.05). Different letters (a and b) by the presented statistically significant result of the post hoc Tukey tests. Values are means ± standard deviations; significant (bold); Risk code means 1 is low-risk; 2 is medium-risk; and 3 are high-risk.
Distribution of the subjects according to their risk differences (n = 60).
| Group | Risk | N (%) | * | |
|---|---|---|---|---|
| Baseline | After 5 Days | |||
| Saline | Low | 0 (00.0) | 0 (00.0) | 0.425 |
| Moderate | 26 (86.6) | 25 (83.3) | ||
| High | 4 (13.4) | 5 (16.7) | ||
|
| Low | 0 (00.0) | 3 (10.0) | 0.051 |
| Moderate | 27 (90.0) | 27 (90.0) | ||
| High | 3 (10.0) | 0 (00.0) | ||
* p-values are determined by Fisher’s exact test (p < 0.05).
Comparison of changes in the cariview according to gender (n = 60).
| Cariview | Female ( | Male ( | ||
|---|---|---|---|---|
| Saline | Saline | |||
| Baseline | 51.19 ± 11.06 | 50.11 ± 11.25 | 71.46 ± 13.91 | 74.00 ± 13.91 |
| 0.746 | 0.770 | |||
| Treatment | 54.15 ± 8.86 | 44.43 ± 7.94 | 57.35 ± 1.37 | 42.50 ± 10.07 |
|
|
| |||
| After 5 days | 60.97 ± 5.89 | 44.58 ± 10.28 | 57.35 ± 1.37 | 49.40 ± 7.12 |
|
|
| |||
†p-values are determined by independent t-test (p < 0.05); Values are means ± standard deviations; significant (bold).
Clinical outcomes were observed between the groups.
| Variables | Group | Mean ± SD | ||||
|---|---|---|---|---|---|---|
| Before | Treatment | After 5 Days | * | |||
|
| Maxilla | Saline | 41.81 ± 34.84 a | 45.30 ± 31.70 a | 35.71 ± 37.00 a | 0.868 |
|
| 64.80 ± 51.50 a | 40.58 ± 21.40 a | 0.00 ± 0.00 b |
| ||
| ¥ | 0.334 | 0.756 |
| |||
| Mandibular | Saline | 83.00 ± 57.91 a | 14.50 ± 11.35 b | 16.67 ± 14.30 b |
| |
|
| 83.00 ± 57.91 a | 10.50 ± 9.79 b | 0.00 ± 0.00 b |
| ||
| ¥ | 1.000 | 0.490 |
| |||
|
| Maxilla | Saline | 127,537.76 ± 98,642.17 a | 119,800.90 ± 110,133.95 a | 124,878.57 ± 71,101.00 a | 0.988 |
|
| 153,728.50 ± 133,372.23 a | 42,408.68 ± 26,692.10 a | 110,578.89 ± 55,820.33 a | 0.059 | ||
| ¥ | 0.688 | 0.071 | 0.677 | |||
| Mandibular | Saline | 56,727.96 ± 30,115.95 a | 56,101.40 ± 26,700.44 a | 56,808.07 ± 23,433.67 a | 0.998 | |
|
| 90,897.70 ± 65,432.98 a | 25,941.37 ± 13,166.15 b | 89,438.63 ± 56,597.73 a |
| ||
| ¥ | 0.205 |
| 0.196 | |||
|
| Maxilla | Saline | 387528.97 ± 156553.26 a | 378413.10 ± 203472.95 a | 370,530.17 ± 149,524.05 a | 0.982 |
|
| 279,862.30 ± 152,068.99 a | 253,726.33 ± 140,596.78 a | 245,293.78 ± 127,744.71 a | 0.888 | ||
| ¥ | 0.182 | 0.173 | 0.097 | |||
| Mandibular | Saline | 274,498.13 ± 119,897.44 a | 281,772.50 ± 132,463.89 a | 281,772.50 ± 132,463.89 a | 0.992 | |
|
| 210,164.80 ± 134,786.75 a | 55,076.30 ± 20,612.73 b | 32,903.89 ± 10,128.22 b |
| ||
| ¥ | 0.333 |
|
| |||
¥p-values are determined by independent t-test, * p-values are determined by one-way ANOVA and Tukey tests (p < 0.05).; Different letters (a and b) by the presented statistically significant result of the post hoc Tukey tests; Values are means ± standard deviations.; significant (bold).